More Press Releases

View Older Stories View Newer Stories

Dec 6, 2025 12:25PM Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
Dec 6, 2025 12:17PM Worthington Steel Issues Statement Regarding Klöckner & Co SE
Dec 6, 2025 12:00PM RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative
Dec 6, 2025 11:01AM Watchung Hardscaping & Erosion Control: Retaining Wall Installations Announced
Dec 6, 2025 11:27AM Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
Dec 6, 2025 02:20PM Is Digitap ($TAP) Crypto Presale the Next Momentum Play?
Dec 6, 2025 11:24AM Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
Dec 6, 2025 01:58PM Digitap ($TAP) Volume Explodes in Final 24 Hours of Cyber Monday Sale
Dec 6, 2025 11:00AM LiberNovo Goes Global: New Markets & A Vision for Healthy Workspaces
Dec 6, 2025 11:00AM Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
Dec 6, 2025 10:30AM Ascent Solutions Appoints Previous Microsoft Sales Leader Jeff Mutschler as Senior Vice President of Alliances
Dec 6, 2025 10:15AM Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
Dec 6, 2025 10:05AM Lordsbook Launches Its New App & Is Leading The Way To Christian Community & Discipleship
Dec 6, 2025 10:00AM When to Choose Veneers vs. Partial Dentures
Dec 6, 2025 10:00AM JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
Dec 6, 2025 10:00AM JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
Dec 6, 2025 09:45AM Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual Meeting
Dec 6, 2025 09:25AM Midwest MSP Titans of the Industry Recognizes GoTech IT Solutions as 2025 Awards Finalist
Dec 6, 2025 09:30AM Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
Dec 6, 2025 09:30AM Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
Dec 6, 2025 09:30AM Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at
Dec 6, 2025 09:30AM Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematolog
Dec 6, 2025 09:30AM Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
Dec 6, 2025 09:30AM Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
Dec 6, 2025 09:30AM Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Dec 6, 2025 09:20AM Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
Dec 6, 2025 09:00AM Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Dec 6, 2025 08:35AM NMDP℠ Demonstrates Scientific Leadership in Expanding Patient Access to Lifesaving Cell Therapy at ASH 2025
Dec 6, 2025 08:30AM Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies
Dec 6, 2025 08:30AM Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Dec 6, 2025 08:05AM Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist
Dec 6, 2025 08:05AM Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meet
Dec 6, 2025 08:05AM Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compo
Dec 6, 2025 08:00AM Collect Ticket Entries For McLuck's Win A Car Giveaway This Christmas
Dec 6, 2025 08:00AM Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
Dec 6, 2025 08:00AM Canada’s Tenth Costco Business Centre is now open in East Gwillimbury
Dec 6, 2025 08:00AM SANDALS AND BEACHES RESORTS IN JAMAICA REOPEN TODAY
Dec 6, 2025 08:00AM ReAlta Announces Promising Phase 2 Data Demonstrating Rapid Clinical Responses and Target Engagement in Steroid-Refractory Acute GvHD at the ASH 2025 Annual Meeting
Dec 6, 2025 08:00AM Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
Dec 6, 2025 08:00AM Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
Dec 6, 2025 08:00AM Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Societ
Dec 6, 2025 08:00AM Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Dec 6, 2025 10:35AM Sunnov Investment: Huawei, ZTE Win Vietnam 5G Deal
Dec 6, 2025 10:29AM 5 Advanced Manufacturing Trends in 2026 and Beyond
Dec 6, 2025 07:15AM Studies Highlight Innovative Approaches to Improving Patient Care and Outcomes
Dec 6, 2025 07:15AM BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows
Dec 6, 2025 07:04AM SplashCoins Drops 200+ New Games for December -- More Wins, More Fun, More Holiday Excitement
Dec 6, 2025 07:05AM Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation
Dec 6, 2025 07:03AM Move Over Chanel and Patek: 18K Gold Edition of 'Twas the Night Before Christmas Just Entered the Luxury Collector Market
Dec 6, 2025 07:01AM Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
View Newer Stories View Older Stories